VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 206 filers reported holding VIR BIOTECHNOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $18,439,854 | +55.3% | 728,560 | +18.3% | 0.00% | +33.3% |
| Q3 2022 | $11,873,916 | -22.1% | 615,867 | +2.9% | 0.00% | -25.0% |
| Q2 2022 | $15,240,331 | +7.1% | 598,364 | +8.2% | 0.00% | +33.3% |
| Q1 2022 | $14,226,169 | -31.7% | 553,117 | +11.2% | 0.00% | -25.0% |
| Q4 2021 | $20,827,000 | +21.6% | 497,420 | +26.4% | 0.00% | 0.0% |
| Q3 2021 | $17,132,000 | +24.2% | 393,669 | +35.0% | 0.00% | +33.3% |
| Q2 2021 | $13,790,000 | -46.8% | 291,675 | -42.3% | 0.00% | -50.0% |
| Q1 2021 | $25,918,000 | +69.4% | 505,527 | -11.5% | 0.01% | +50.0% |
| Q4 2020 | $15,298,000 | -30.3% | 571,244 | -10.7% | 0.00% | -33.3% |
| Q3 2020 | $21,948,000 | -34.1% | 639,338 | -21.4% | 0.01% | -40.0% |
| Q2 2020 | $33,305,000 | +10506.7% | 812,916 | +3151.7% | 0.01% | – |
| Q4 2019 | $314,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
| SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
| Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
| SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
| ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
| Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
| DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
| Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |